-
Business Wire via Yahoo! Finance - Mon Nov 23, 7:00 am ET
WEST HAVEN, Conn.----NanoViricides, Inc. , announced today that Dr. Eugene Seymour, MD MPH, CEO of the Company, presented lifetime data from the recent FluCide™ animal study on November 19th at the Influenza Congress USA 2009 in Washington, DC .
-
Center for Infectious Disease Research and Policy - Mon Nov 16, 6:19 pm ET
FDA backs off on Gulf Coast oyster safety plan In response to protests from the oyster industry and politicians, the Food and Drug Administration (FDA) recently announced the suspension, pending further study, of a plan to prevent the summertime contamination of Gulf Coast oysters by Vibrio vulnificus bacteria.
-
Business Wire via Yahoo! Finance - Fri Nov 20, 6:00 am ET
SAN DIEGO----Inovio Biomedical Corporation , a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets.
-
Fox News - Fri Nov 20, 6:15 pm ET
Vaccine-maker Novavax said Friday it plans to sell 6.8 million shares of its stock.
-
Market Watch - Fri Nov 20, 11:10 am ET
Drug stocks cling to the flat line in morning activity while shares of Inovio Biomedical soar on positive clinical data for its new DNA-based flu vaccine.
-
Newswise - Mon Nov 16, 12:57 pm ET
New methods of studying avian influenza strains and visually mapping their movement around the world will help scientists more quickly learn the behavior of the pandemic H1N1 flu virus, researchers say.
-
GlobeNewswire via Yahoo! Finance - Fri Nov 20, 11:31 am ET
CALGARY, Alberta -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on Inovio Biomed Corp . Emerging Stock Report is currently offering a complimentary trial subscription to the investment community.
-
KXAN 36 Austin - Thu Nov 19, 11:59 pm ET
Fighting flu is the goal of a group of UT researchers who worry today's drugs won't pack the same punch tomorrow.
-
Fairbanks Daily News-Miner - Thu Nov 19, 12:37 pm ET
ANCHORAGE, Alaska - A Fairbanks man who died Saturday is the tenth death in Alaska from swine flu. Seven of the deaths have been Fairbanks-related. The state Health Department says it's looking ...
-
Tulsa World - Thu Nov 19, 3:44 am ET
Jack and Bobbie Campbell waited in line for about an hour at Expo Square on Wednesday to get the H1N1 vaccine.
-
The Providence Journal - Wed Nov 18, 10:17 pm ET
PROVIDENCE - Physicians should treat the high fever and dry cough of classic flu promptly with antiviral medications, whether or not patients test positive for H1N1, the virus which is making people sick in epidemic proportions.
-
PR Newswire via Yahoo! Finance - Thu Nov 19, 7:00 am ET
DxNA, a molecular diagnostics company headquartered in St. George, Utah, announced today that the DxNA GeneSTAT PCR system has successfully completed evaluation studies under the direction of a California laboratory supported by the Joint FAO/IAEA Programme in Food and Agriculture.
-
Center for Infectious Disease Research and Policy - Wed Nov 18, 8:50 pm ET
Nov 18, 2009 (CIDRAP News) – Federal officials, along with representatives from four vaccine companies, appeared before two US House of Representatives committees today to answer questions about why the nation hasn't stretched scarce pandemic vaccine supply with adjuvants and if a more federally directed distribution system might help vaccine get to more high-risk patients.
-
The Martha's Vineyard Times - Wed Nov 18, 7:12 pm ET
It was only a matter of time. Last week a 13-year-old cat in Iowa had a confirmed case of swine flu. Now before you panic and kick kitty out of the house, let's take a calm, scientific look at the facts.
-
redOrbit - Wed Nov 18, 10:09 am ET
BEIJING, Nov. 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with the U.S.